Article metrics

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

 

Online download statistics by month:

Online download statistics by month: September 2022 to October 2022

AbstractFullPdf
Sep 202210001043308
Oct 2022722738192
Total17221781500